Lineage Cell Therapeutics, Inc.’s LCTX share price has dipped by 5.08%, which has investors questioning if this is right time ...

In a new study, researchers from the University of Copenhagen have successfully created stem cells that are better at ...

Researchers have developed a genetic "barcoding" method to trace how stem cells in embryos become neurons and inner ear cells ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, and the Christopher & Dana ...

Lineage Cell Therapeutics, Inc. (NYSE:LCTX), with a market capitalization of $114 million, reported today that it has successfully completed a production run for two different product candidates ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M.